A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms of generalized anxiety disorder (GAD) in clinical trials. However, there is ...

If you’re dealing with depression or anxiety, relief can sometimes be hard to find. At Sunrise Psychiatry Inc, Dr. Sonni ...

Their work suggests a new target for treating anxiety disorders and related conditions and demonstrates a general strategy, based on a method called photopharmacology, for mapping drug effects on ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Common drugs taken by up to 10million Americans for anxiety and high blood pressure may lower the risk of stroke in some at-risk people, a study suggests. Propranolol, a type of drug known as a ...

The United States' Food and Drug Administration has required boxed warnings for the drug since 2020. Montelukast is known to ...

Marijuana access introduces an alternative treatment to traditional prescription medication that may provide easier access ...

Seaport Therapeutics has moved swiftly to shore up its finances with a $225 million second round to fund the development of improved drugs for depression and anxiety. General Atlantic led the ...

Major depressive disorder (MDD), also referred to as clinical depression or depression, is a mood disorder where a person has a consistently low or depressed mood and no longer finds interest in ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.